Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charles Okeke Nnadi has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aminosteroids from Buxaceae and Apocynaceae Plants as Antiprotozoal Agents: Structural Diversity and Structure–Activity Relationships

    by Justus W. Mukavi, Lizanne Schäfer, Lara U. Szabó, Charles O. Nnadi, Julia B. Althaus, Pascal Mäser, Thomas J. Schmidt

    As part of our search for new natural chemicals with bioactivity against protozoan pathogens, we have previously reported on the isolation, identification and antiprotozoal activity of over 100 alkaloids with an aminosteroid or related scaffold. We have now investigated the hypothesis that these chemically related compounds also share common mechanisms of action regarding their activity against Trypanosoma brucei rhodesiense (human East African trypanosomiasis) and Plasmodium falciparum (tropical malaria). Furthermore, their cytotoxic activity against mammalian cells (L6 rat skeletal myoblasts) was also included in the investigation. We found that mammalian cytotoxicity is generally lower and there is only a low degree of mutual correlation between the susceptibility of the two parasites and mammalian cells to the compounds’ toxic effects. With the molecular targets being unknown, the 3D-QSAR study was conducted using the Open3Dqsar software. The resulting models show the main structural features influencing the different biological effects. They indicate that indeed related molecular targets underly the cytotoxic, antitrypanosomal and antiplasmodial activity based on structural determinants sufficiently different enough to warrant a significant level of parasite-selectivity. The results of this study offer structural explanations for the observed differences in aminosteroids’ action against the mentioned pathogens and provide a starting point for optimization and simplification of the natural structures towards leads for antiprotozoal drug development.

  • Open Access

    Network Pharmacology Analysis of Piper guineense-Derived Phytochemical Compounds for Wound Healing Activity

    by Chizelum C. Mgbe, Paul C. Onwuasoanya, Sandra I. Abana, James E. Sunday, Blessing E. Ugwuodo, Lilian I. Nweke, Emmanuel C. Okoro, Amara A. Nwose, Chikaodili S. Ugwuanyi, Charles O. Nnadi, et al.

    Piper guineense, a West African spice and medicinal plant, is traditionally used for wound healing, though its molecular mechanisms remain unclear. This study employed a network pharmacology approach to elucidate its therapeutic potential. Phytochemicals were evaluated for drug-likeness via SwissADME, while wound-related differentially expressed genes (DEGs) were retrieved from the Gene Expression Omnibus. Overlapping targets were identified using Venn analysis, and protein–protein interaction networks were constructed with STRING and analyzed in Cytoscape. Functional enrichment and KEGG pathway analyses were performed using ShinyGO. Of 211 compounds, 210 exhibited drug-like properties, linked to 1153 receptors, with 248 overlapping wound-related DEGs. Hub genes PTGS2, GSK3B, HSP90AA1, EGFR, and GAPDH were identified, regulating inflammation, angiogenesis, migration, and metabolism. Despite reliance on computational predictions and limited experimental validation, the findings reveal P. guineense’s multi-target wound healing potential and demonstrate the application of network pharmacology in bridging ethnomedicine with molecular insights.

  • In-vitro and in-silico evaluation of interactions between Camellia sinensis leaf extract and selected 4-aminoquinoline antimalarial drugs

    by Chinwe M. Onah, Cynthia C. Agbo, God’SWill O. Okonofua, Charles O. Nnadi, Cyprian O. Onyeji

  • Open Access

    Network pharmacology identification of Aframomum-derived anti-arthritic agents

    by James E. Sunday, Emmanuel C. Okoro, Amara A. Nwose, Chikaodili S. Ugwuanyi, Chizelum C. Mgbe, Paul C. Onwuasoanya, Sandra I. Abana, Blessing E. Ugwuodo, Charles O. Nnadi, Wilfred O. Obonga

    Arthritis remains a pervasive global health challenge characterised by chronic inflammation, joint stiffness, and cartilage degradation, often necessitating the long-term use of conventional pharmacotherapeutic agents that carry significant side effects. This study investigated the mechanism of the anti-arthritic potential of Aframomum -derived compounds using network pharmacology and molecular docking approaches. Phytochemicals from the Aframomum genus were screened for drug-like properties using SwissADME. Potential biological targets of these compounds were predicted using the SwissTargetPrediction tool. The arthritis-related genes were retrieved from the Gene Expression Omnibus (GEO) database and were matched with the predicted genes using the bioinformatics and genome web tool. A protein-protein interaction network of the differentially expressed genes (DEGs) was constructed using the STRING web tool and further analysed in Cytoscape to identify the hub genes. The interaction of essential bioactive Aframomum compounds and selected hub targets of arthritis was simulated using molecular docking. Of the 111 compounds, 110 showed drug-like properties with 1043 biological targets, while the GEO identified 723 arthritis-related genes. A total of 67 DEGs, representing potential therapeutic targets with CXCL8, IL-6, JUN, PTGS2 and STAT1 as top hub genes, were identified. Functional enrichment analysis using ShinyGO and KEGG databases demonstrated involvement of these genes in the arthritic pathway. Specifically, galanolactone, oleanolic acid, nerolidol, zambesiacolactone A and B were identified as key Aframomum compounds interacting with these hub genes. Molecular docking simulations showed that core hub targets of arthritis, such as human IL6 and PTGS2, bound strongly with oleanolic acid and zambesiacolactones with sub-nanomolar inhibition constants (Ki < 1 nm). The study showed that Aframomum phytochemicals exert their anti-arthritic effect via a multi-target and multi-pathway mechanism, providing a computational validation of their traditional ethnomedicinal use.


  • Open Access

    Predictive Modeling of Malaria Risk Using the Nigerian Demographic and Health Survey Data

    by JohnPaul C. Ugwu, Thecla O. Ayoka, Charles O. Nnadi, Wilfred O. Obonga

    Malaria continues to pose a significant public health challenge in Nigeria, yet there has not been much research utilizing machine-learning techniques to forecast malaria risk. This study developed a machine-learning model that predicts malaria risk by leveraging demographic, environmental, and GPS data from the Nigerian Demographic and Health Survey (DHS) covering the years 2000 to 2020. The dataset was pre-processed and split into a training set (with 406 respondents) and a test set (with 102 respondents). Random Forest (RF), Gradient Boosting (GB) and Linear Regression (LR) algorithms were employed to assess their predictive performance. The RF stood out with the best accuracy, achieving the lowest mean squared error (MSE = 0.0053) and the highest coefficient of determination (R2 = 0.6364). Thus, RF was recognized as the most effective model for predicting malaria risk. The regression equation with positive coefficients (like population density = 0.0141, travel time = 0.0019, minimum temperature = 0.0082, temperature in January = 0.0265, and dry land surface temp = 0.0368) indicate that higher feature values are associated with increased malaria prevalence, while negative coefficients (such as rainfall = −0.0122, nightlights composite = −0.03, potential evapotranspiration = −0.09 and insecticide treated nets = −0.02) suggest that as the feature increases, the prevalence decreases. This study underscores the potential of the RF approach in improving early predictions of malaria risk and can guide targeted interventions to control malaria in areas at high risk.

  • Open Access

    Dusts and De-dusting of Natural Products Datasets: A Critical Review of the Challenges

    by Shadrach C. Eze, Lilian I. Nweke, Frances Ojobor, Wande M. Oluyemi, Charles O. Nnadi

    Machine learning and artificial intelligence have become an established part of natural-products (NP) drug discovery. From bioactivity, hit-identification and lead optimization to toxicity and pharmacokinetic profiling, predictive models have sustained increased momentum. While many review works have focused on the models underlying predictions in NP drug discovery, a detailed understanding of how the quality of the data impacts the predictive process is still lacking. In this narrative review, we undertake the task of unravelling the shortcomings of the current datasets we have, the bottlenecks presented and ways to alleviate them. NP datasets are plagued by unique challenges—including chemical complexity, sparse bioactivity data, experimental variability, and significant toxicity data gaps—which collectively act as "dust", obscuring reliable predictions. We show how embedding data quality checks during curation and standardization during modelling can improve predictive performance. Additionally, data enrichment by augmentation and hybridization with multi-omics will be a good addition to NP drug discovery. We conclude that giving equal priority to data quality as algorithmic complexity ensures more reliable prediction and translation of AI-driven NP research into tangible therapeutic outcomes.

  • Open Access

    TransQSAR-pf: A Bio-Informed QSAR Framework Using Plasmodium falciparum Stress Signatures for Enhanced Antiplasmodial Activity Prediction

    by Favour O. Igwezeke, Charles O. Nnadi

    Traditional QSAR modeling relies solely on molecular descriptors, neglecting the biological state of target organisms. While prior approaches have integrated biological data with molecular features for activity prediction, we developed TransQSAR-pf, a methodological framework that integrates Plasmodium falciparum transcriptomic stress signatures with molecular descriptors to construct biologically informed activity prediction models. Applied to 125 triazolopyrimidine derivatives, the framework distilled 764 transcriptomic features into 13 key predictors through Boruta selection, constructing an interpretable model (R2 = 0.762, RMSE = 0.470) that demonstrated improved performance over the baseline QSAR-only model (R2 = 0.719, RMSE = 0.529). Biological mapping revealed that 71.2% of feature importance derived from conserved unknown-function genes, representing largely uncharacterized stress response pathways that correlate with compound efficacy and warrant experimental characterization, demonstrating the framework’s utility for generating mechanistic hypotheses. This work presents a novel computational pipeline for building biology-aware QSAR models that prioritize experimental targets for antimalarial discovery.


  • Open Access

    Mechanisms, Significance, Detection and Emerging Therapies for Carbapenem‐Resistant Enterobacterales: A Scoping Review

    by Oluchi Judith Osuala, Chioma Miracle Ojiako, Chioma C. Ezeuko, Kasso Terhemen, Constance Chinyere Ezemba, Victor O. Etikudike, Charles O. Nnadi, Angus Nnamdi Oli

    Background: Carbapenems are among the most important broad‐spectrum β‐lactam antibiotics for the treatment of severe infections caused by multi–drug‐resistant Gram‐negative bacteria. However, the global emergence and dissemination of carbapenem‐resistant Enterobacterales (CRE), particularly carbapenemase‐producing Enterobacterales (CPE), have significantly compromised their clinical utility. Resistance is primarily driven by the acquisition of genes encoding carbapenemases, often in combination with porin alterations, efflux pump overexpression and AmpC hyperproduction, resulting in limited treatment options and increased morbidity and mortality. Objectives: This scoping review aimed to synthesise current evidence on the molecular mechanisms of carbapenem resistance, the classification and epidemiology of carbapenemases, advances in diagnostic approaches and emerging therapeutic strategies for CRE infections. Methods: A scoping review was conducted in accordance with the PRISMA extension for Scoping Reviews (PRISMA‐ScR). Literature published between January 2005 and March 2026 was identified through systematic searches of PubMed/MEDLINE, Scopus and Google Scholar. Eligible studies included original research articles, surveillance reports, systematic reviews and clinical guidelines addressing carbapenem resistance mechanisms, carbapenemase epidemiology, diagnostics or treatment strategies. Data were extracted and synthesised using a narrative and thematic approach. Results: Carbapenemase production was identified as the predominant mechanism of resistance among CRE, with KPC, NDM, OXA‐48‐like, VIM and IMP enzymes driving global dissemination. Considerable geographical variation exists in carbapenemase distribution, reflecting differences in antimicrobial use, surveillance capacity and healthcare infrastructure. Advances in molecular diagnostics, including polymerase chain reaction, loop‐mediated isothermal amplification, whole‐genome sequencing and rapid immunochromatographic assays, have improved detection and surveillance. Emerging therapeutic options, particularly novel β‐lactam/β‐lactamase inhibitor combinations and cefiderocol, have expanded treatment possibilities, although resistance to newer agents continues to emerge. Conclusions: CREs remain a major global public health threat. Strengthened surveillance systems, improved access to rapid diagnostics, carbapenemase‐directed therapeutic strategies and continued antimicrobial development are essential to limit the spread of resistance and improve clinical outcomes.

  • Application of machine learning models in predicting malaria prevalence in Nigeria: an analysis of the 2015–2020 demographic and health surveys

    by Thecla Okeahunwa Ayoka, Charles Okeke Nnadi

    Malaria is a major public health problem, especially in sub-Saharan Africa and other developing countries, where majority of malaria cases and deaths occur. This study developed a machine learning (ML) model to accurately diagnose malaria in rural communities in Nigeria, based on patients’ symptoms and other clinical information, using low-cost and readily available diagnostic tools. The model was trained on a 2020 Nigerian Demographic and Health Surveys Program Geospatial Covariate datasets containing clinical information of patients in Nigeria. ML approaches were preferred over traditional statistical methods due to their ability to handle high-dimensional, non-linear relationships and interactions among a diverse set of variables. Regression based-algorithms were used to identify and predict patterns as a continuous outcome allowing finer-grained spatial and demographic insights than binary classification would predict. The models underwent rigorous validation using cross validation and holdout testing to assess generalizability and minimize overfitting. The closeness of the predicted malaria incidence scores and the experimental scores indicates the robustness of the ML model. The coefficient determination scores of random forest regressor (RFR), multiple linear regression, and ridge models were 0.9937, 0.9916, and 0.9924 respectively for the test set. This demonstrates the competence of the models’ prediction abilities. The RFR model’s learning curve results showed a recurring pattern. The model’s performance on the test dataset consistently improved as the volume of data increased. By shifting from reactive diagnostics to proactive risk prediction, health authorities can more effectively allocate resources, improve intervention timing, and reach underserved rural communities with precision.